乳酸水平与改良年龄校正qSOFA评分对危重儿科患者死亡率的预测价值
本研究为回顾性单中心分析,纳入2019年1月1日至2023年12月31日期间入住ICU的≤18岁患者共1156例(中位年龄20.2个月,死亡率6.2%)。非存活者的基线乳酸水平(3.7 [2.4-4.9] vs. 2.1 [1.4-3.4] mmol/L,p<0.01)和改良年龄校正qSOFA评分(3 vs. 1 [0-2],p<0.01)均显著高于存活者。基线乳酸的预测价值为0.699(敏感性59.7%,特异性74.9%)。改良年龄校正qSOFA评分的预测能力优于基线乳酸,但受限于特异性较低;两者联合的预测价值与单用改良年龄校正qSOFA评分相似,当ROC曲线下面积达0.836时,联合两项指标可提高特异性。按不同基线乳酸浓度进行亚组分析显示,乳酸水平和改良年龄校正qSOFA评分并未影响危重儿科患者的临床决策。作者认为,基线乳酸与改良年龄校正qSOFA评分对危重患儿死亡率的预测能力较低,联合应用似乎可增强预测能力,但仍不足以作为确定性临床决策的充分预测指标。
要点
- 在1156例危重儿科患者中,非存活者基线乳酸为3.7 [2.4-4.9] mmol/L,显著高于存活者的2.1 [1.4-3.4] mmol/L(p<0.01)。
- 非存活者改良年龄校正qSOFA评分为3,显著高于存活者的1 [0-2](p<0.01)。
- 基线乳酸预测死亡的ROC曲线下面积为0.699(敏感性59.7%,特异性74.9%)。
- 改良年龄校正qSOFA评分预测能力优于基线乳酸,但特异性有限;两者联合的预测价值与单用qSOFA评分相似,ROC曲线下面积达0.836时联合可提高特异性。
- 按不同基线乳酸浓度进行亚组分析显示,乳酸水平和改良年龄校正qSOFA评分并未影响危重儿科患者的临床决策。
适用人群与场景
- 年龄≤18岁、于2019年1月1日至2023年12月31日期间入住ICU的危重儿科患者。
研究设计与关键结果
- 研究类型:回顾性单中心分析;样本量1156例;中位年龄20.2个月;死亡率6.2%。
- 非存活者基线乳酸为3.7 [2.4-4.9] mmol/L,存活者为2.1 [1.4-3.4] mmol/L(p<0.01)。
- 非存活者改良年龄校正qSOFA评分为3,存活者为1 [0-2](p<0.01)。
- 基线乳酸预测死亡的ROC曲线下面积为0.699(敏感性59.7%,特异性74.9%)。
- 改良年龄校正qSOFA评分预测能力优于基线乳酸,但受限于特异性较低。
- 基线乳酸联合改良年龄校正qSOFA评分的预测价值与单用改良年龄校正qSOFA评分相似;当ROC曲线下面积达0.836时,联合两项指标可提高特异性。
- 按不同基线乳酸浓度进行亚组分析显示,乳酸水平和改良年龄校正qSOFA评分并未影响危重儿科患者的临床决策。
证据类型、等级与局限
- 证据类型:回顾性单中心分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基线乳酸与改良年龄校正qSOFA评分对危重患儿死亡率的预测能力较低,联合应用似乎可增强预测能力,但仍不足以作为确定性临床决策的充分预测指标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: This study aimed to evaluate the predictive accuracy of baseline lactate levels and the modified age-adjusted quick Sequential Organ Failure Assessment (qSOFA) score in forecasting mortality in critically ill pediatric patients.
METHODS: A retrospective single-center analysis was conducted on patients aged ≤18 years admitted to the intensive care unit (ICU) between January 1, 2019, and December 31, 2023. The predictive performance of lactate levels at baseline and that of the modified age-adjusted qSOFA score were compared in terms of mortality.
RESULTS: Among 1156 patients (median age: 20.2 months; mortality rate: 6.2 %), non-survivors exhibited significantly higher baseline lactate levels (3.7 [2.4-4.9] vs. 2.1 [1.4-3.4] mmol/L, *p* < 0.01) and modified age-adjusted qSOFA scores (3 (Bulgarelli et al., 2020; Filho et al., 2016a; Issa et al., 2021) vs. 1 [0-2], *p* < 0.01) compared to survivors. The baseline lactate level exhibited a predictive value of 0.699(sensitivity: 59.7 %; specificity: 74.9 %). The modified age-adjusted qSOFA score showed greater predictive capability than baseline lactate levels in critically ill pediatric patients; nevertheless, it is constrained by limited specificity. The predictive value of baseline lactate level paired combined with the modified age-adjusted qSOFA score was similar to that of the modified age-adjusted qSOFA score alone. Specifically, when the area under the Receiver Operating Characteristic (ROC) curve reached 0.836, the specificity enhanced with the integration of these two indicators. However, lactate levels and the modified age-adjusted qSOFA score did not influence clinical decision-making in critically ill pediatric patients, as demonstrated by subgroup analysis according to different baseline lactate concentrations.
CONCLUSION: Baseline lactate and the modified age-adjusted qSOFA score had a low-accuracy ability to predict mortality in critically ill children. Although the combination of lactate and the modified age-adjusted qSOFA score appears to enhance predictive ability, it remains an insufficient predictor for making definitive clinical decisions in critically ill children.
参考来源
- Wang Y, Wu Q, Zhu X, et al. Lactate levels and the modified age-adjusted quick sequential organ failure assessment (qSOFA) score are fair predictors of mortality in critically ill pediatric patients. Am J Emerg Med. 2025. PMID: 40086093. doi:10.1016/j.ajem.2025.03.010
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。